SMC - May 2023 decisions

SMC

9 May 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on five medicines.

Empagliflozin (Jardiance) was accepted for the treatment of patients with chronic heart failure.

Read SMC press release

Michael Wonder

Posted by:

Michael Wonder